One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
eTRANSAFE: data science to empower translational safety assessment
Ferran Sanz, François Pognan, Thomas Steger-Hartmann, Carlos DÃaz, Shoji Asakura, Alexander Amberg, Nathalie Bécourt-Lhote, Niklas Blomberg, Nicolas Bosc, Katharine Briggs, Frank Bringezu, Claire Brulle-Wohlhueter, Søren Brunak, Ruud Bueters, Giulia Callegaro, Salvador Capella-Gutierrez, Emilio Centeno, Javier Corvi, Mark T. D. Cronin, Philip Drew, Guillemette Duchateau-Nguyen, Gerhard F. Ecker, Sylvia Escher, Eloy Felix, … David Wilkinson
doi : 10.1038/d41573-023-00099-5
Volume 22 Issue 8, August 2023
Personalized cancer vaccines pass first major clinical test
Elie Dolgin
FDA approves first gene therapy for Duchenne muscular dystrophy, despite internal objections
Asher Mullard
Massive misuse of chemical probes undermines the utility of these tools
Asher Mullard
Trends in the use of liquid biopsy in oncology
Wen Xie1,2 , Smruthi Suryaprakash3 , Chun Wu4 , Andrew Rodriguez5 & Sven Fraterman
Herding in the drug development pipeline
Christian Fougner, Julie Cannon, Lydia The, Jeffrey F. Smith & Olivier Leclerc
Selective activation of Wnt ameliorates idiopathic pulmonary fibrosis
M. Teresa Villanueva
Trends in the approval of cancer therapies by the FDA in the twenty-first century
Emma C. Scott, Andrea C. Baines, Yutao Gong, Rodney Moore Jr, Gulsum E. Pamuk, Haleh Saber, Ashim Subedee, Matthew D. Thompson, Wenming Xiao, Richard Pazdur, V. Ashutosh Rao, Julie Schneider & Julia A. BeaverÂ
Antibody–drug conjugates come of age in oncology
Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert & Alain BeckÂ
Disease modification in inflammatory skin disorders: opportunities and challenges
Thomas BieberÂÂ
